Armon Sharei
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
Armon R.
Sharei was the founder of SQZ Biotechnologies Co. (2013), holding the title of President, Chief Executive Officer & Director.
Dr. Sharei is the founder of Portal Biotechnologies Inc. (2023), holding the title of President, CEO, Secretary, Treasurer & Director.
Dr. Sharei is currently the Chief Executive Officer at Sqz Biotechnologies, Inc. Dr. Sharei is currently an Independent Director at Genenta Science SpA, starting in 2024.
Dr. Sharei's education includes an undergraduate degree from Stanford University and a doctorate from the Massachusetts Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 30/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director/Miembro de la Junta | 02/05/2024 |
Sqz Biotechnologies, Inc. | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Director Ejecutivo | 30/11/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Sqz Biotechnologies, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.